AMYLYX PHARMACEUTICALS INC (AMLX) Stock Cash Flow
NASDAQ:AMLX - Nasdaq - US03237H1014 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -218.86M | -301.74M | 49.27M | -198.38M | -87.93M | |||
| Depreciation Amortization | 745.00K | 904.00K | 1.09M | 487.00K | 52.00K | |||
| Change In Working Capital | -55.15M | -45.83M | -65.68M | -2.13M | 4.74M | |||
| Taxes Paid | 463.00K | 708.00K | 6.39M | 27.00K | N/A | |||
| Other non cash items | 66.28M | 179.02M | 27.24M | 20.14M | 8.34M | |||
| OPERATING CASH FLOW | -206.98M | -167.65M | 11.92M | -179.87M | -74.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -36.30M | -36.36M | -1.24M | -2.53M | -353.00K | |||
| Other Investing Activity | 67.48M | 112.01M | 93.29M | -236.46M | -46.05M | |||
| INVESTING CASH FLOW | 31.18M | 75.65M | 92.05M | -238.99M | -46.41M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 0.00 | 25.90M | |||
| Stock Issued/Repurchased | 67.23M | 2.13M | 6.99M | 434.64M | 135.34M | |||
| Other Financing Activity | -1.35M | -1.78M | -3.45M | -2.85M | -2.73M | |||
| FINANCING CASH FLOW | 65.88M | 348.00K | 3.54M | 431.79M | 158.51M | |||
| Exchange Rate Effect | -131.00K | -438.00K | 160.00K | -65.00K | 13.00K | |||
| CHANGE IN CASH | -110.06M | -92.08M | 107.67M | 12.87M | 37.31M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -206.98M | -167.65M | 11.92M | -179.87M | -74.80M | |||
| Capital Expenditure | -36.30M | -36.36M | -1.24M | -2.53M | -353.00K | |||
| FREE CASH FLOW | -243.29M | -204.01M | 10.68M | -182.40M | -75.15M | |||
All data in USD